BMEA · Biomea Fusion, Inc.
$2.03
+0.12 (+6.28%)
At close · Sep 4
Going-concern doubt
— flagged Aug 5, 2026
Substantial doubt about the company's ability to continue as a going concern.
“In connection with the preparation of this Quarterly Report on Form 10-Q for the period ended June 30, 2026, our management has concluded that there is substantial doubt as to whether we can continue as a going concern for the twelve months following the issuance of this Quarterly Report on Form 10-Q. Our ability to continue as a going concern is dependent upon raising capital to maintain current operations and continue research and development efforts. We plan to raise additional capital to fund our operations through public or private equity offerings, debt financings, and/or potential collaborations and license arrangement or other sources. There is no assurance, however, that any additional financing or any revenue-generating collaboration will be available when needed or that we will be able to obtain financing or enter into a collaboration on terms acceptable to us. Based on our current operating plan, we will not be able to continue as a going concern over the next twelve months unless we raise additional capital by other means. These factors raise substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Aug 5, 2026
Market Cap
$147.14M
Shares
72.48M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Michael J.M. Hitchcock | Interim Chief Executive Officer and Principal Executive Officer Rainer (Ramses) Erdtmann Chief Operating Officer, President, Principal Financial Officer and Principal Accounting Officer | $2,569,516 |
| Thomas Butler | Former Chief Executive Officer and Former Chairman of the Board | $661,963 |
| Juan Pablo Frias | Former Chief Medical Officer | $549,037 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Thomas Butler | Former Chief Executive Officer and Former Chairman of the Board | $5,106,387 |
| Franco Valle | Former Chief Financial Officer Rainer (Ramses) Erdtmann Chief Operating Officer and President | $2,078,067 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Juan Pablo Frias | Chief Medical Officer | $3,932,476 |
| Thomas Butler | Former Chief Executive Officer and Former Chairman of the Board | $2,707,310 |
| Franco Valle | Former Chief Financial Officer Rainer (Ramses) Erdtmann Chief Operating Officer and President | $1,299,867 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Thomas Butler | Chief Executive Officer and Chairman of theBoard | $921,140 |
| Franco Valle | Chief Financial Officer | $651,773 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Thomas Butler | Chief Executive Officer and Chairman of the Board Rainer (Ramses) Erdtmann Chief Operating Officer and President | $6,661,207 |
| Franco Valle | Chief Financial Officer | $2,959,193 |
| Ramses Erdtmann | Chief Operating Officer and President | $2,900,049 |
Key facts
CIK
1840439
CUSIP
09077A106
13F (30d)
44 filings
44 filers
Visit website
Investor relations